Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
Kintsugi Therapeutics has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Kintsugi Therapeutics's investors include Capital Cell.
Kintsugi Therapeutics is headquartered in Barcelona, Spain.
Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
Kintsugi Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kintsugi Therapeutics — Funding & Investors." VCBacked, November 12, 2021, https://www.vcbacked.co/company/kintsugi-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Kintsugi Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kintsugi-therapeutics
{{cite web |title=Kintsugi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kintsugi-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated